TRVI logo

Trevi Therapeutics (TRVI) Company Overview

Profile

Full Name:

Trevi Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 7, 2019

Indexes:

Not included

Description:

Trevi Therapeutics is a biopharmaceutical company focused on developing innovative treatments for chronic cough and other conditions. They aim to improve patients' quality of life by creating effective therapies using their expertise in drug development and clinical research.

Events Calendar

Earnings

Next earnings date:

Mar 20, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 20, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 8, 25 D. Boral Capital
Buy
Dec 16, 24 D. Boral Capital
Buy
Dec 13, 24 HC Wainwright & Co.
Buy
Dec 12, 24 Needham
Buy
Dec 12, 24 HC Wainwright & Co.
Buy
Dec 12, 24 D. Boral Capital
Buy
Dec 4, 24 Needham
Buy
Dec 4, 24 HC Wainwright & Co.
Buy
Dec 4, 24 D. Boral Capital
Buy
Nov 8, 24 Needham
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Trevi Therapeutics?
  • Does Trevi Therapeutics pay dividends?
  • What sector is Trevi Therapeutics in?
  • What industry is Trevi Therapeutics in?
  • What country is Trevi Therapeutics based in?
  • When did Trevi Therapeutics go public?
  • Is Trevi Therapeutics in the S&P 500?
  • Is Trevi Therapeutics in the NASDAQ 100?
  • Is Trevi Therapeutics in the Dow Jones?
  • When was Trevi Therapeutics's last earnings report?
  • When does Trevi Therapeutics report earnings?
  • Should I buy Trevi Therapeutics stock now?

What is the ticker symbol for Trevi Therapeutics?

The ticker symbol for Trevi Therapeutics is NASDAQ:TRVI

Does Trevi Therapeutics pay dividends?

No, Trevi Therapeutics does not pay dividends

What sector is Trevi Therapeutics in?

Trevi Therapeutics is in the Healthcare sector

What industry is Trevi Therapeutics in?

Trevi Therapeutics is in the Biotechnology industry

What country is Trevi Therapeutics based in?

Trevi Therapeutics is headquartered in United States

When did Trevi Therapeutics go public?

Trevi Therapeutics's initial public offering (IPO) was on May 7, 2019

Is Trevi Therapeutics in the S&P 500?

No, Trevi Therapeutics is not included in the S&P 500 index

Is Trevi Therapeutics in the NASDAQ 100?

No, Trevi Therapeutics is not included in the NASDAQ 100 index

Is Trevi Therapeutics in the Dow Jones?

No, Trevi Therapeutics is not included in the Dow Jones index

When was Trevi Therapeutics's last earnings report?

Trevi Therapeutics's most recent earnings report was on Nov 6, 2024

When does Trevi Therapeutics report earnings?

The next expected earnings date for Trevi Therapeutics is Mar 20, 2025

Should I buy Trevi Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions